DGX CIK: 1022079

Quest Diagnostics Incorporated

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
2.74
FY22:
1.90
FY23:
2.37
FY24:
2.39
FY25:
2.38
(positive)
Change from FY21 to FY25
billions USD
FY21:
10.9
FY22:
10.9
FY23:
11.7
FY24:
13.8
FY25:
13.8
Total assets
Change from FY21 to FY25
billions USD
FY21:
13.6
FY22:
12.8
FY23:
14.0
FY24:
16.2
FY25:
16.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
1.75
FY22:
1.55
FY23:
1.82
FY24:
2.17
FY25:
2.28
(negative)
Change from FY21 to FY24
billions USD
FY21:
5.30
FY22:
5.28
FY23:
5.79
FY24:
7.09
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
6.44
FY22:
5.89
FY23:
6.31
FY24:
6.78
FY25:
7.17

All amounts in billions USD Data sources:SEC EDGARTwelve Data